Noom Med vs Found 2026: GLP-1 Weight Loss Programs Compared
Noom Med and Found both pair GLP-1 medication with coaching for weight loss. We compare pricing, coaching models, clinical evidence, and medication options side-by-side to help you choose — and show where a medication-focused provider like Trimi fits in.
Written by Trimi Medical Team. Medically reviewed by Dr. Amanda Foster, MD. Our team updates competitor reviews when pricing, medication access, or program structures change so patients can compare options with current data.
Quick links: Semaglutide treatment, tirzepatide treatment, and cheapest GLP-1 injections guide.
More on GLP-1 Provider Comparisons
Noom vs Found for Weight Loss: What You Need to Know
If you are comparing noom vs found weight loss programs, you are choosing between two telehealth platforms that combine GLP-1 medication with coaching support. Noom Med pairs semaglutide prescriptions with the Noom app's behavioral psychology coaching. Found pairs GLP-1 medications with its own weight-loss-focused coaching and clinical team. Both charge significantly more than medication-only providers because they bundle coaching into the subscription price.
Noom Med vs Found, defined: Noom Med is the prescription arm of Noom, the popular calorie-tracking and behavioral change app, now expanded to include GLP-1 medications such as semaglutide and tirzepatide. Found is a standalone telehealth weight loss company built specifically around prescription weight loss medications, offering compounded semaglutide and tirzepatide alongside coaching and behavioral support. Both are legitimate telehealth providers with licensed medical teams, but they differ meaningfully in coaching style, pricing structure, and overall cost.
The central question for most patients is whether the coaching component justifies the premium. Clinical trial data consistently shows that GLP-1 medication is the primary driver of weight loss outcomes. The STEP 1 trial demonstrated 14.9% body weight loss with semaglutide at 68 weeks, with both the treatment and placebo groups receiving lifestyle counseling (Wilding et al., NEJM, 2021). This means the coaching both groups received contributed roughly the same amount, while the medication accounted for the difference. Patients who want the medication without paying a premium for coaching may prefer a provider like Trimi, which offers semaglutide at $99 per month and tirzepatide at $125 per month with clinical oversight included.
Noom Med vs Found vs Trimi: Side-by-Side Comparison
| Feature | Noom Med | Found | Trimi |
|---|---|---|---|
| Semaglutide monthly cost | $149–$209/mo | $129–$199/mo | $99/mo |
| Tirzepatide monthly cost | Not widely offered | $199–$299/mo | $125/mo |
| Additional app/coaching fee | $32–$70/mo possible | Included in price | None |
| Effective monthly total (sema) | $181–$279/mo | $129–$199/mo | $99/mo |
| Coaching model | App-based CBT + psychology | Weight-loss-focused coaching | Clinical guidance |
| Medication included in price | Yes (med subscription) | Yes | Yes |
| Flat dose-independent pricing | No | No | Yes |
| Provider visits included | Yes | Yes | Yes |
| Contract commitment | Varies by plan | Varies by plan | None (month-to-month) |
| Cancellation penalties | Possible | Possible | None |
| 12-month total (semaglutide) | $2,172–$3,348 | $1,548–$2,388 | $1,188 |
| Best for | Patients who value Noom's behavioral psychology app alongside medication | Patients wanting weight-loss coaching at a moderate price | Patients wanting the best value for clinical GLP-1 care |
All pricing is approximate and based on publicly available information as of April 2026. Noom Med's effective monthly total includes the potential additional Noom app subscription fee. Verify current pricing directly with each provider before enrolling.
Pricing Breakdown: What You Actually Pay
Cost is the single most important differentiator for the majority of patients considering GLP-1 treatment, and the pricing structures between Noom Med and Found differ in ways that are not immediately obvious. Understanding the true monthly cost requires looking beyond the headline medication price.
Noom Med Pricing
Noom Med charges $149 to $209 per month for its semaglutide medication subscription. This covers the prescription, clinical oversight, and medication delivery. However, Noom Med's coaching component often requires a separate Noom app subscription costing $32 to $70 per month, depending on the plan and billing cycle. Some patients report that bundled pricing reduces the combined cost, but the total effective monthly expense for Noom Med with full coaching access typically ranges from $181 to $279 per month for semaglutide. Over twelve months, that totals $2,172 to $3,348 for medication and coaching combined. For a detailed look at potential Noom Med side effects, see our dedicated guide.
Found Pricing
Found charges $129 to $199 per month for semaglutide and $199 to $299 per month for tirzepatide. Found's pricing includes coaching and clinical services in the subscription, so there is no separate app fee. However, Found uses dose-dependent pricing, which means your monthly cost increases as your dose escalates during the titration schedule. A patient who starts at $129 per month may find themselves paying $199 per month after reaching a maintenance dose. Over twelve months, Found's total semaglutide cost ranges from $1,548 to $2,388. Patients considering Found should review our guide on Found weight loss side effects before enrolling.
Trimi Pricing
Trimi charges $99 per month for semaglutide and $125 per month for tirzepatide. This price is flat and dose-independent, meaning you pay the same amount whether you are on a starting dose or a maintenance dose. There are no additional fees for app access, coaching, consultations, or shipping. The twelve-month total for semaglutide at Trimi is $1,188 with no risk of price escalation. Compared to Noom Med's midpoint cost of approximately $2,760 and Found's midpoint of approximately $1,968, Trimi saves patients $780 to $1,572 annually on semaglutide alone. For a broader comparison of affordable options, see our cheapest GLP-1 injections 2026 guide.
Coaching Approaches: Behavioral Psychology vs Weight Loss Focus
The coaching component is what Noom Med and Found use to justify their higher prices. Both platforms include coaching, but the methodology and delivery differ meaningfully. Understanding these differences helps you decide whether the coaching premium is worth paying.
Noom Med Coaching
Rooted in cognitive behavioral therapy (CBT) principles
App-based daily lessons on food psychology and habit formation
Color-coded food classification system (green, yellow, red)
Daily calorie logging and meal tracking within the Noom app
Group coaching with other Noom users
Goal-setting and progress tracking tools
Focus on changing your relationship with food over time
Found Coaching
Weight-loss-specific coaching and behavioral support
In-app messaging with assigned health coaches
Medication management integrated into coaching workflow
Behavioral science-informed content and tools
Community features and peer support within the app
Side effect management guidance alongside coaching
Focus on practical strategies for weight loss with medication
Noom Med's coaching is better suited for patients who want a structured behavioral psychology program that addresses the underlying habits and thought patterns behind overeating. The CBT-based approach is evidence-informed and provides a comprehensive framework for long-term behavioral change. Found's coaching is more practically oriented toward the weight loss journey itself, integrating medication management with lifestyle adjustments and side effect support.
The coaching question most patients should ask
Both Noom Med and Found charge a significant premium for coaching. The honest question is whether you will consistently engage with the coaching tools over 12 or more months. Many patients report high engagement in the first few weeks that tapers significantly by month three. If you suspect you will primarily rely on the medication rather than the coaching, a medication-focused provider like Trimi delivers the same clinical outcome at substantially lower cost.
Clinical Evidence: What Actually Drives Weight Loss
Neither Noom Med nor Found has published peer-reviewed clinical trials demonstrating that their specific coaching programs produce outcomes superior to medication with standard clinical oversight. The clinical evidence for GLP-1 weight loss comes from large-scale randomized controlled trials of the medications themselves, not from any individual telehealth platform's coaching methodology.
Semaglutide: STEP 1 Trial Results
The landmark STEP 1 trial enrolled 1,961 adults and demonstrated that semaglutide 2.4 mg produced an average of 14.9% body weight loss over 68 weeks, compared to 2.4% with placebo. Critically, both groups received lifestyle counseling, meaning the medication — not the counseling — drove the 12.5 percentage point difference (Wilding et al., New England Journal of Medicine, 2021). This is the foundational evidence supporting every semaglutide-based program, including Noom Med, Found, and Trimi.
Tirzepatide: SURMOUNT-1 Trial Results
The SURMOUNT-1 trial enrolled 2,539 adults and showed that tirzepatide produced 15% to 20.9% body weight loss over 72 weeks at various doses, compared to 3.1% with placebo. Both groups received lifestyle counseling. The dual GIP/GLP-1 mechanism of tirzepatide produced even greater weight loss than semaglutide alone (Jastreboff et al., New England Journal of Medicine, 2022). Found and Trimi both offer tirzepatide; Noom Med's tirzepatide availability is more limited.
Intensive Coaching vs Standard Counseling
A 2024 study by Wadden et al. in the New England Journal of Medicine compared semaglutide plus intensive behavioral therapy against semaglutide with standard counseling. Both groups lost significant weight, and the intensive therapy group did not demonstrate a clinically meaningful advantage over the standard counseling group. This suggests that intensive coaching programs — the kind charged as premiums by Noom Med and Found — may not produce materially better outcomes than basic clinical guidance alongside GLP-1 medication.
SELECT Cardiovascular Trial
The SELECT trial demonstrated a 20% reduction in major adverse cardiovascular events with semaglutide in patients with obesity and established cardiovascular disease (Lincoff et al., New England Journal of Medicine, 2023). This benefit is attributable to the medication itself, independent of any coaching methodology, further reinforcing that the pharmacological intervention is the primary therapeutic driver.
The clinical evidence is consistent: GLP-1 medications produce substantial, clinically meaningful weight loss. Coaching and behavioral support are beneficial for overall health and habit formation, but they are not the primary mechanism of weight loss in GLP-1 treatment. This distinction matters because Noom Med and Found charge a premium specifically for their coaching components. Patients should decide whether that premium aligns with their individual needs and budget, knowing that the medication itself accounts for the vast majority of expected weight loss.
Medication Options and Access
All three providers prescribe semaglutide for weight loss. Found and Trimi both offer tirzepatide as well. Noom Med has been more limited in its tirzepatide availability. The active pharmaceutical ingredient is identical regardless of which provider prescribes it. Semaglutide works through the same GLP-1 receptor agonist mechanism whether it comes through Noom Med, Found, or Trimi, and tirzepatide works through the same dual GIP/GLP-1 mechanism regardless of provider.
Noom Med medications
Primarily semaglutide. Tirzepatide availability varies. Compounded and brand-name options may be available depending on supply.
Found medications
Semaglutide ($129–$199/mo) and tirzepatide ($199–$299/mo). Primarily compounded formulations from partner pharmacies.
Trimi medications
Semaglutide ($99/mo) and tirzepatide ($125/mo). Compounded formulations from FDA-registered pharmacies. Flat pricing at all doses.
Who Should Choose Noom Med
Noom Med is the right fit if you specifically want Noom's behavioral psychology approach alongside your GLP-1 medication. Patients who have had success with the Noom app in the past and want to combine that methodology with prescription medication may find value in Noom Med's integrated experience. The CBT-based framework is well-designed for patients who struggle with emotional eating or food psychology and want structured daily guidance.
Noom Med is not the right choice if cost is a significant factor. At $181 to $279 per month effective cost, Noom Med is the most expensive option among these three providers. The separate medication and app subscriptions can create billing complexity. Patients who are primarily interested in the medication and do not plan to engage deeply with daily app lessons may be paying a substantial premium for features they will not use. If you are currently on Noom Med and looking for alternatives, our guide to canceling Noom Med covers the transition process step by step.
Who Should Choose Found
Found is the right fit if you want coaching support tailored specifically to weight loss with GLP-1 medication at a moderate price. Found's platform integrates medication management with coaching in a way that feels purpose-built for the GLP-1 weight loss experience. The inclusion of both semaglutide and tirzepatide gives patients more medication flexibility than Noom Med currently offers.
Found is not the right choice if you want pricing transparency or flat-rate billing. Dose-dependent pricing means your cost rises as treatment progresses, and the difference between the lowest and highest tiers is significant. Some patients report difficulty with Found's cancellation process and unexpected charges. If you are currently on Found and considering a switch, see our guide to canceling Found for detailed steps.
Who Should Choose Trimi
Trimi is the right fit if you want effective GLP-1 treatment at the lowest sustainable price without paying for coaching services you may not fully use. Flat pricing, no contracts, no hidden fees, and responsive clinical support make Trimi the most financially straightforward option. Access to both semaglutide and tirzepatide at dose-independent pricing means your cost never increases as your treatment progresses.
Trimi is not the right choice if you specifically want intensive app-based coaching (Noom Med) or structured weight-loss behavioral support (Found). Trimi's model focuses on clinical medication management rather than comprehensive behavioral programming. The trade-off is clear: patients who choose Trimi save $780 to $2,160 annually but forgo the coaching platforms that Noom Med and Found provide. For patients who are self-motivated or prefer to supplement their GLP-1 treatment with their own exercise and nutrition strategies, this trade-off strongly favors Trimi.
The Bottom Line
Medication drives the clinical outcome
GLP-1 medication is the primary cause of weight loss in all three programs. The STEP 1 and SURMOUNT-1 trials demonstrate 14.9% to 20.9% weight loss from medication, with coaching contributing a marginal additional benefit at best. When you pay more at Noom Med or Found, you are primarily paying for coaching, not for a better medical outcome.
Noom Med costs the most, Found sits in the middle, Trimi costs the least
For semaglutide over twelve months: Noom Med totals $2,172 to $3,348, Found totals $1,548 to $2,388, and Trimi totals $1,188. The annual savings of $360 to $2,160 by choosing Trimi are substantial, especially for a treatment that often continues for years.
Start with the medication, add coaching if you need it
Rather than starting with an expensive coaching-plus-medication program and downgrading later, consider starting with a cost-effective medication provider like Trimi. If you find you need additional behavioral support after beginning treatment, standalone coaching apps and nutritional counseling are available independently and often at lower cost than the premium charged by Noom Med or Found.
Frequently Asked Questions
Is Noom Med the same as regular Noom?
No. Regular Noom is a behavioral weight loss app that uses cognitive behavioral therapy techniques without medication. Noom Med is a separate clinical program that pairs GLP-1 medications like semaglutide with Noom's app-based coaching platform. Noom Med requires a medical evaluation and prescription, while the original Noom app is available to anyone. The Noom Med subscription fee covers the medication and clinical oversight, and the Noom app subscription is typically an additional cost of $32 to $70 per month unless bundled.
Does Found prescribe tirzepatide?
Yes. Found offers both semaglutide and tirzepatide as part of its GLP-1 weight loss program. Tirzepatide through Found costs approximately $199 to $299 per month depending on the dose and plan selected. For comparison, Trimi offers tirzepatide at $125 per month with flat pricing regardless of dose.
Which is cheaper, Noom Med or Found?
Found is generally less expensive than Noom Med for semaglutide. Found charges $129 to $199 per month for semaglutide, while Noom Med charges $149 to $209 per month for the medication subscription alone, with a possible additional Noom app fee of $32 to $70 per month. However, both are significantly more expensive than medication-focused providers like Trimi, which charges $99 per month for semaglutide with all clinical services included.
Do I need coaching to lose weight on GLP-1 medication?
Clinical evidence suggests that GLP-1 medication is the primary driver of weight loss. The STEP 1 trial demonstrated 14.9 percent body weight loss with semaglutide compared to 2.4 percent with placebo, and coaching was provided to both groups (Wilding et al., NEJM, 2021). While behavioral coaching can support healthy habit formation, the medication produces the majority of the clinical effect. Many patients achieve excellent results with medication and standard clinical oversight alone, without premium coaching programs.
Can I switch from Noom Med or Found to a cheaper provider?
Yes. Switching from Noom Med or Found to another GLP-1 provider is straightforward. Your medication type and current dose transfer without interruption. The main consideration is timing the switch to avoid a gap in your medication supply. Review any contract terms or cancellation policies before switching. Detailed guides are available for canceling Noom Med and canceling Found.
Are Noom Med and Found legitimate medical providers?
Yes. Both Noom Med and Found employ licensed medical providers who evaluate patients, write prescriptions, and provide ongoing clinical oversight. Both partner with licensed pharmacies to dispense medication. They are legitimate telehealth platforms operating within standard medical and regulatory frameworks. The difference between them and other providers is in their supplementary services and pricing, not in the legitimacy of their medical care.
What happens if I stop paying for coaching but want to keep my medication?
If you stop your Noom Med or Found subscription, you will lose access to both the coaching platform and your medication prescription. These programs bundle coaching and medication together, so you cannot keep one without the other. To continue GLP-1 treatment without coaching, you would need to transfer your care to a medication-focused provider like Trimi, which charges $99 per month for semaglutide with clinical oversight included.
Sources & References
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002.
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216.
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes. N Engl J Med. 2023;389(24):2221-2232.
- Wadden TA, et al. Intensive behavioral therapy and semaglutide for obesity. N Engl J Med. 2024.
- Noom Health, Inc. Noom Med official program and pricing information. 2026.
- Found Health, Inc. Found weight loss official program and pricing information. 2026.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Individual results vary. Trimi is a competing provider; this comparison is presented fairly but readers should verify current pricing and program details directly with each provider. Pricing information reflects publicly available data as of April 2026 and is subject to change.